• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

XRHealth Sends VR Headsets for Mental Health to Treat Astronauts in Space

by Syed Hamza Sohail 11/03/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • XRHealth, the leading healthcare platform in Spatial computing, announces today that for the first time ever, a virtual reality headset will be sent to space to treat astronauts for mental health conditions during their next space mission targeted for launch on November 5th.
  • XRHealth partnered with Nord-Space Aps and HTC VIVE to configure the VIVE Focus 3 headset to be compatible with the microgravity conditions of space.

Virtual Assistance Driven Mental Health Initiative for Astronauts in Space Missions

While on a space mission, astronauts live in isolation and in non-stimulating and highly stressful environments that could potentially lead to mental health conditions. To address this, Nord-Space Aps created a virtual assistance mental balance initiative aimed to address astronauts’ specific needs to maintain mental health while in orbit. Danish astronaut Andreas Mogensen will be the first astronaut in space to use the VR headset for preventative care during his 6-8 month mission with NASA Crew-7.

“Astronauts are essentially isolated during their missions for months and years at a time and are confined to small spaces with limited contact with friends and family,” says Per Lundahl Thomsen, Chief Technology Officer at Nord-Space Aps. “Creating a virtual platform that addresses their mental health needs while in isolation is imperative for them to maintain a healthy lifestyle when they return. We partnered with companies that provide the most advanced technologies that could be adapted fo

The VR therapy will occur using the HTC VIVE Focus 3 headset equipped with a custom simulator mode designed to function effectively in a microgravity environment. Historically, employing a VR headset in such conditions presented significant challenges related to tracking and orientation. This was due to the constant jittering, rolling, and drifting of the content, leading to motion sickness and rendering the content in the headset unreadable for astronauts. In a microgravity setting, there are no natural gravity vectors to establish orientation, resulting in a gradual drift that rendered the VR headset both unusable and unstable. Previous ventures with different VR headsets encountered issues with losing tracking within just a few minutes of use. Collaboratively, Nord-Space Aps, HTC, and XRHealth undertook the task of engineering a VR platform capable of functioning in space by implementing a simulator mode and a specialized tracking methodology via the controllers.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |